Skip to main content
SpringerLink
Log in

Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

  • Living reference work entry
  • First Online:
Book cover Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 70 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References and Further Reading

  • Bacher, U., Haferlach, T., Schnittger, S., et al. (2011). Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia. British Journal of Haematology, 153, 149–167.

    Article  PubMed  Google Scholar 

  • Itzykson, R., Kosmider, O., Renneville, A., et al. (2013). Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 31, 2428–2436.

    Article  CAS  Google Scholar 

  • Kohlmann, A., Grossmann, V., Klein, H. U., et al. (2010). Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 28, 3858–3865.

    Article  CAS  Google Scholar 

  • Kosmider, O., Gelsi-Boyer, V., Ciudad, M., et al. (2009). TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia. Haematologica, 94, 1676–1681.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Orazi, A., Bennett, J. M., Germing, U., Brunning, R. D., Bain, B. J., Cazzola, M., Foucar, K., Thiele, J., Baumann, I., Niemeyer, C. M., Hasserhian, R. P., & Malcovati, L. (2017). Myelodysplastic/myeloproliferative neoplasms. Lyon: IARC.

    Google Scholar 

  • Ricci, C., Fermo, E., Corti, S., et al. (2010). RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant. Clinical Cancer Research, 16, 2246–2256.

    Article  CAS  PubMed  Google Scholar 

  • Wang, S. A., Hasserjian, R. P., Fox, P. S., et al. (2014). Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood, 123, 2645–2651.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA

    Julia T Geyer & Attilio Orazi

Authors
  1. Julia T Geyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Attilio Orazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julia T Geyer .

Editor information

Editors and Affiliations

  1. NIJMEGEN, The Netherlands

    J.H.J.M. van Krieken

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Geyer, J.T., Orazi, A. (2018). Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN). In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_4774-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_4774-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation